UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Maintenance immunotherapy in stage IV cancer patients who have a clinical benefit from chemotherapy

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3021-3021

2017

Volltextzugriff (PDF)

Immunotherapy in Patients with Less than Complete Response to Chemotherapy

Anticancer research, 2009-02, Vol.29 (2), p.567-572

2009

Volltextzugriff (PDF)

Prolonged Disease Control after Myeloablative Chemotherapy, Autologous Transplantation and Immunotherapy in High-risk Early Breast Cancer

Anticancer research, 2010-01, Vol.30 (1), p.209-216

2010

Volltextzugriff (PDF)

Abstract CT109: Adjuvant ovarian suppression in high risk premenopausal breast cancer: ten-year follow-up of a phase I-II study

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT109-CT109

2016

Volltextzugriff (PDF)

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

The lancet oncology, 2018-04, Vol.19 (4), p.474-485

2018

Volltextzugriff (PDF)

Long-term Follow-up of Pegylated Liposomal Doxorubicin and Oxaliplatin in Recurrent Ovarian Cancer

Journal of integrative oncology, 2016, Vol.5 (2)

2016

Volltextzugriff (PDF)

Dose-finding Study of Docetaxel Added to Ifosfamide and Cisplatin Followed by Concomitant Capecitabine and Radiotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Anticancer research, 2006-05, Vol.26 (3B), p.2317-2324

2006

Volltextzugriff (PDF)

Maintenance immunotherapy in patients with advanced cancer (AC): Long term follow-up of a phase II study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14005-e14005

2015

Volltextzugriff (PDF)

Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer

Anticancer research, 2015-12, Vol.35 (12), p.6847-6853

2015

Volltextzugriff (PDF)

Paclitaxel Plus Gemcitabine in Advanced Non-small Cell Lung Cancer Patients with Low Performance Status

Anticancer research, 2005-01, Vol.25 (1B), p.409-414

2005

Volltextzugriff (PDF)

Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin-eluting beads compared with lipiodol

Oncology reports, 2012-05, Vol.27 (5), p.1377-1383

2012

Volltextzugriff (PDF)

Gonadotropin‐releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma

Cancer, 2006-02, Vol.106 (3), p.514-523

2006

Volltextzugriff (PDF)

Abstract CT301: Late disease recurrence in estrogen receptor positive (ER+) premenopausal breast cancer (BC)

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.CT301-CT301

2014

Volltextzugriff (PDF)

Abstract 5366: Extended phase II study of maintenance immunotherapy in advanced cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5366-5366

2012

Volltextzugriff (PDF)

Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes

The oncologist (Dayton, Ohio), 2016-11, Vol.21 (11), p.1298-1305

2016

Volltextzugriff (PDF)

Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.537-537

2014

Volltextzugriff (PDF)

Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study

Gynecologic oncology, 2010-02, Vol.116 (2), p.202-207

2010

Volltextzugriff (PDF)

Abstract 5055: The role of estrogens and vascular endothelial growth factor (VEGF) in premenopausal breast cancer carginogenesis and disease progression

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5055-5055

2011

Volltextzugriff (PDF)

A multicenter, open-label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high-risk, early breast cancer (HRBC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e11041-e11041

2012

Volltextzugriff (PDF)

Abstract 480: Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.480-480

2013

Volltextzugriff (PDF)

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.234-242

2015

Volltextzugriff (PDF)

Beta-interferon, retinoids and tamoxifen in metastatic breast cancer : Long-term follow-up of a phase II study

Oncology reports, 2009-04, Vol.21 (4), p.1011-1016

2009

Volltextzugriff (PDF)

Abstract 3722: Ovarian suppression with gonadotropin-releasing hormone analogues (Gn-RH) in high risk premenopausal breast cancer patients (PM-HR-BC): decrease of T regulatory cells (T-regs) and of vascular endothelial growth factor (VEGF)

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3722-3722

2010

Volltextzugriff (PDF)

Premenopausal Hormone-responsive Breast Cancer with Extensive Axillary Nodes Involvement: Total Estrogen Blockade and Chemotherapy

Anticancer research, 2011-02, Vol.31 (2), p.671-676

2011

Volltextzugriff (PDF)

Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer

Oncology letters, 2013-04, Vol.5 (4), p.1117-1122

2013

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Oncology
(28)
Humans
(26)
Middle Aged
(23)
Female
(22)
Adult
(20)
Aged
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Tumors
(14)
Biological And Medical Sciences
(13)
Male
(13)
Medical Sciences
(13)
Treatment Outcome
(12)
Interleukin-2
(9)
Aged, 80 And Over
(8)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(8)
Disease-Free Survival
(8)
Immunotherapy
(8)
Breast Cancer
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maintenance immunotherapy in stage IV cancer patients who have a clinical benefit from chemotherapy

Immunotherapy in Patients with Less than Complete Response to Chemotherapy

Prolonged Disease Control after Myeloablative Chemotherapy, Autologous Transplantation and Immunotherapy in High-risk Early Breast Cancer

Abstract CT109: Adjuvant ovarian suppression in high risk premenopausal breast cancer: ten-year follow-up of a phase I-II study

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Long-term Follow-up of Pegylated Liposomal Doxorubicin and Oxaliplatin in Recurrent Ovarian Cancer

Dose-finding Study of Docetaxel Added to Ifosfamide and Cisplatin Followed by Concomitant Capecitabine and Radiotherapy in the Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Maintenance immunotherapy in patients with advanced cancer (AC): Long term follow-up of a phase II study

Adjuvant Ovarian Suppression, High-dose Chemotherapy and Immunotherapy for Premenopausal Patients with High-risk Breast Cancer

Paclitaxel Plus Gemcitabine in Advanced Non-small Cell Lung Cancer Patients with Low Performance Status

Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin-eluting beads compared with lipiodol

Gonadotropin‐releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma

Abstract CT301: Late disease recurrence in estrogen receptor positive (ER+) premenopausal breast cancer (BC)

Abstract 5366: Extended phase II study of maintenance immunotherapy in advanced cancer

Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes

Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study

Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study

Abstract 5055: The role of estrogens and vascular endothelial growth factor (VEGF) in premenopausal breast cancer carginogenesis and disease progression

A multicenter, open-label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high-risk, early breast cancer (HRBC)

Abstract 480: Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study

Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study

Beta-interferon, retinoids and tamoxifen in metastatic breast cancer : Long-term follow-up of a phase II study

Abstract 3722: Ovarian suppression with gonadotropin-releasing hormone analogues (Gn-RH) in high risk premenopausal breast cancer patients (PM-HR-BC): decrease of T regulatory cells (T-regs) and of vascular endothelial growth factor (VEGF)

Premenopausal Hormone-responsive Breast Cancer with Extensive Axillary Nodes Involvement: Total Estrogen Blockade and Chemotherapy

Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer

Suchergebnisse filtern